Renée Gal

2020

In 2020, Renée Gal earned a total compensation of $4.1M as Executive Vice President and CFO at Jazz Pharmaceuticals.

Compensation breakdown

Bonus$25,000
Non-Equity Incentive Plan$405,000
Option Awards$1,382,012
Salary$484,616
Stock Awards$1,816,868
Other$9,904
Total$4,123,400

Gal received $1.8M in stock awards, accounting for 44% of the total pay in 2020.

Gal also received $25K in bonus, $405K in non-equity incentive plan, $1.4M in option awards, $484.6K in salary and $9.9K in other compensation.

Rankings

In 2020, Renée Gal's compensation ranked 2,758th out of 13,090 executives tracked by ExecPay. In other words, Gal earned more than 78.9% of executives.

ClassificationRankingPercentile
All
2,758
out of 13,090
79th
Division
Manufacturing
1,055
out of 5,621
81st
Major group
Chemicals And Allied Products
392
out of 2,254
83rd
Industry group
Drugs
338
out of 1,954
83rd
Industry
Pharmaceutical Preparations
246
out of 1,459
83rd

Pay ratio

Renée Gal's Pay$4,123,400
Median Employee's Pay$234,935
Pay Ratio

18

to 1

In 2020, the annual total compensation of Renée Gal was $4,123,400.

The annual total compensation of the median employee at Jazz Pharmaceuticals was $234,935.

The ratio of Renée Gal's pay to the pay of median employee was therefore 18 to one.

Source: SEC filing on June 11, 2021.

Gal's colleagues

We found five more compensation records of executives who worked with Renée Gal at Jazz Pharmaceuticals in 2020.

2020

Bruce Cozadd

Jazz Pharmaceuticals

Chief Executive Officer

2020

Kim Sablich

Jazz Pharmaceuticals

Executive Vice President and General Manager, North America

2020

Daniel Swisher

Jazz Pharmaceuticals

Chief Operating Officer

2020

Robert Ianonne

Jazz Pharmaceuticals

Chief Medical Officer

2020

Robert MSCE

Jazz Pharmaceuticals

Executive Vice President, Global Head of Research and Development

News

You may also like